CAM
IONS icon

Creekmur Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Creekmur Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.54K Hold
100
– – ﹤0.01% 549
2025
Q2 		$3.95K Hold
100
– – ﹤0.01% 594
2025
Q1 		$3.02K Hold
100
– – ﹤0.01% 576
2024
Q4 		$3.5K Hold
100
– – ﹤0.01% 540
2024
Q3 		$4.01K Hold
100
– – ﹤0.01% 566
2024
Q2 		$4.77K Hold
100
– – ﹤0.01% 587
2024
Q1 		$4.33K Hold
100
– – ﹤0.01% 577
2023
Q4 		$5.06K Buy
+100
New +$4.79K ﹤0.01% 591

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creekmur Asset Management's IONS Position: Q3 2025 in Review

Creekmur Asset Management held its Ionis Pharmaceuticals (IONS) position steady in Q3 2025 at 100 shares worth $6.54K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Creekmur Asset Management first reported a position in IONS in Q4 2023 and has held it in 8 quarters since. 435 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • Creekmur Asset Management held 100 shares of Ionis Pharmaceuticals worth $6.54K as of Q3 2025.
  • Creekmur Asset Management left its Ionis Pharmaceuticals share count unchanged in Q3 2025.
  • Ionis Pharmaceuticals made up ﹤0.01% of Creekmur Asset Management's portfolio in Q3 2025, its #549 holding.
  • Creekmur Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • 435 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.